128 related articles for article (PubMed ID: 15450421)
1. Spontaneous multiple mutations show both proximal spacing consistent with chronocoordinate events and alterations with p53-deficiency.
Hill KA; Wang J; Farwell KD; Scaringe WA; Sommer SS
Mutat Res; 2004 Oct; 554(1-2):223-40. PubMed ID: 15450421
[TBL] [Abstract][Full Text] [Related]
2. Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype.
Hill KA; Buettner VL; Heidt A; Chen LL; Li W; Gonzalez KD; Wang JC; Scaringe WA; Sommer SS
Carcinogenesis; 2006 Sep; 27(9):1860-6. PubMed ID: 16597646
[TBL] [Abstract][Full Text] [Related]
3. A novel germline mutation in Big Blue mice.
Crabbe RA; Prtenjaca A; Tarnowski HE; Hill KA
Environ Mol Mutagen; 2009 Mar; 50(2):114-20. PubMed ID: 19107908
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of doublet/multiplet mutations in lung cancers: evidence that a subset arises by chronocoordinate events.
Chen Z; Feng J; Buzin CH; Sommer SS
PLoS One; 2008; 3(11):e3714. PubMed ID: 19005564
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous mutation in Big Blue mice from fetus to old age: tissue-specific time courses of mutation frequency but similar mutation types.
Hill KA; Buettner VL; Halangoda A; Kunishige M; Moore SR; Longmate J; Scaringe WA; Sommer SS
Environ Mol Mutagen; 2004; 43(2):110-20. PubMed ID: 14991751
[TBL] [Abstract][Full Text] [Related]
6. Evidence that proximal multiple mutations in Big Blue transgenic mice are dependent events.
Buettner VL; Hill KA; Scaringe WA; Sommer SS
Mutat Res; 2000 Sep; 452(2):219-29. PubMed ID: 11024481
[TBL] [Abstract][Full Text] [Related]
7. Germline TP53 mutations and Li-Fraumeni syndrome.
Varley JM
Hum Mutat; 2003 Mar; 21(3):313-20. PubMed ID: 12619118
[TBL] [Abstract][Full Text] [Related]
8. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.
Nishino H; Knöll A; Buettner VL; Frisk CS; Maruta Y; Haavik J; Sommer SS
Oncogene; 1995 Jul; 11(2):263-70. PubMed ID: 7624143
[TBL] [Abstract][Full Text] [Related]
9. EGFR somatic doublets in lung cancer are frequent and generally arise from a pair of driver mutations uncommonly seen as singlet mutations: one-third of doublets occur at five pairs of amino acids.
Chen Z; Feng J; Saldivar JS; Gu D; Bockholt A; Sommer SS
Oncogene; 2008 Jul; 27(31):4336-43. PubMed ID: 18372921
[TBL] [Abstract][Full Text] [Related]
10. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.
Kouidou S; Malousi A; Maglaveras N
Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569
[TBL] [Abstract][Full Text] [Related]
11. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice.
Buettner VL; Hill KA; Nishino H; Schaid DJ; Frisk CS; Sommer SS
Oncogene; 1996 Dec; 13(11):2407-13. PubMed ID: 8957082
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation.
Capponcelli S; Pedrini E; Cerone MA; Corti V; Fontanesi S; Alessio M; Bachi A; Soddu S; Ribatti D; Picci P; Helman LJ; Cantelli-Forti G; Sangiorgi L
Hum Mutat; 2005 Aug; 26(2):94-103. PubMed ID: 15977174
[TBL] [Abstract][Full Text] [Related]
13. Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers.
Lamolle G; Marin M; Alvarez-Valin F
Mutat Res; 2006 Aug; 600(1-2):102-12. PubMed ID: 16650445
[TBL] [Abstract][Full Text] [Related]
14. High frequency of de novo mutations in Li-Fraumeni syndrome.
Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
[TBL] [Abstract][Full Text] [Related]
15. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
Wu CC; Shete S; Amos CI; Strong LC
Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210
[TBL] [Abstract][Full Text] [Related]
16. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
Yamada H; Shinmura K; Okudela K; Goto M; Suzuki M; Kuriki K; Tsuneyoshi T; Sugimura H
Carcinogenesis; 2007 Sep; 28(9):2013-8. PubMed ID: 17690113
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
Olive KP; Tuveson DA; Ruhe ZC; Yin B; Willis NA; Bronson RT; Crowley D; Jacks T
Cell; 2004 Dec; 119(6):847-60. PubMed ID: 15607980
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous and induced chromosomal damage and mutations in Bloom Syndrome mice.
Wang Y; Heddle JA
Mutat Res; 2004 Oct; 554(1-2):131-7. PubMed ID: 15450411
[TBL] [Abstract][Full Text] [Related]
20. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
